Richtlijn CVRM feb2013 - KNMP

Freemantle 1999 Freemantle N, Cleland J, Young P, Mason J, Harrison J. Beta blockade after myocardial infarction: a
systematic review and meta regression analysis. BMJ 1999; 318: 1730-1737.
Friedman 2010
Friedman RJ, Dal OE, Rosencher N, Caprini JA, Kurth AA, Francis CW, et al. Dabigatran versus
enoxaparin for prevention of venous thromboembolism after hip or knee arthroplasty: a poold
analysis of three trials. Thromb Res 2010; 126 (3): 175-82.
Galan 2010 Galan P, et al. Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a
randomised placebo controlled trial. BMJ 2010; 341: c6273.
Gao 2011 Gao F, Zhou Yj, Wang ZJ, Yang SW, Nie B, Liu XL, et al. Meta-analysis of the combination of
warfarin and dual antiplatelet therapy afer coronary stenting in patients with indications for
chronic oral anticoalgulation. Int J Cardiol 2011; 148 91): 96-101.
Geber 2002 Geber J, Parra D, Beckey NP en Korman L. Optimizing Drug Therapy in Patients with
Cardiovascular Disease: The Impact of Pharmacist-Managed Pharmacotherapy Clinics in a
Primary Care Setting. Journal of Human Pharmacology and Drug Therapy 2002 (22) 738-747.
Geleedst 2010
Geleedst-De Vooght M, Maitland-van der Zee A-H, Schalekamp T, Mantel-Teeuwese A en
Janssen P. Statin Prescribing in the Elderly in the Netherlands. Drugs & Aging 2010; 7: 589-596.
Gillett 2011 Gillett RC, Norrel A. Considerations for safe use of statins: liver enzyme abnormalities and
muscle toxicity. Am Fam Physician 2011; 83 (6): 711-6.
Ginsberg 2009 Ginsberg JS, Davidson BL, Comp PC, Francis CW, Friedman RJ, Hui MH, et al. Oral thrombin
inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of
venous thromboembolism after knee arthroplasty surgery. J Arthroplasty 2009; 24 (1): 1-9.
Glueck 2006 Glueck CJ, Aregawi D, Agloria M, et al. Rosuvastatin 5 and 10mg/d: a pilot study of the
effects in hypercholesterolemic adults unable to tolerate other statins and reach LDL
cholesterol goals with nonstatin lipid-lowering strategies. Clin Ther 2006; 28: 933-942.
Goodman 2012 Goodman SG, Clare R, pieper KS, Nicolau JC, Storey RF, Cantor WJ, et al. Assocaition of
proton pump inhibitor use on cardiovascular outcomes with clopidogrel and ticagrelor:
insights from the platelet inhibition and patient outcomes trial. Circulation 2012; 125 (8): 978-
86
Gomez 2011 Gomez Sandoval YH, BraganzaMV, daskalopoulo SS. Statin discontinuation in high-risk
patients: a systematic review of the evidence. Curr Pharm Des 2011; 17 (33): 3669-89.
Graham 2004 Graham DJ, et al. Incidence of hospitalized rhabdomyolysis in patients with lipid-lowering
drugs. JAMA 2004; 292: 2585-2590.
Graham 2007 Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, et al. European guidelines
on cardiovascular disease prevention inn clinical practice: full text. Fourth Joint task force of
the
European Society of cardiology and other societies on cardiovascular disease prevention in
clinical
practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev
rehabil 2007; 14 suppl 2: S1-113.
Granger 2011
Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, et al. Apixaban versus
warfarin in patients with atrial fibrillation. N Eng J Med 2011; 365 (11): 981-92.
Greving 2011 Greving JP, Visseren FLJ, de Wit GA, Algra A. Primaire preventive met statines: bij wie
kosteneffectief NTVG 2011; 155 (29): 1286-1290.] en [ Statin treatment for primary
prevention of vascular disease: whom to treat Cost-effectiveness analysis. BMJ 2011; 342:
d1672. Doi:10.1136/bmj.d1672.
Gubitz 2000 Gubitz G, Sandercock P. Acute ischaemic stroke. BMJ 2000; 320: 692-696.
Gueyffier 1999 Gueyffier F et al. Antihypertensive drugs in very old people: a subgroup meta-analysis of
randomized controlled trials. Lancet 1999; 353: 793-796.
Gupta 2011 Gupta A, Thompson PD. The relationship of vitamin D deficiency to statin myopathy.
Systematic review. Atherosclerosis 2011; 215: 23-29.
88
CONCEPT